The MaxDiscovery™ Alkaline Phosphatase (AP) Enzymatic Assay Kit is a plate-based, colorimetric-endpoint assay for the determination of the alkaline phosphatase enzyme in serum. Alkaline phosphatase (AP) is a ubiquitously-expressed intracellular enzyme which catalyzes the hydrolysis of organic phosphoesters. AP is a clinically important protein marker in serum because its level changes in response to a number of health-related states. For example, changes in AP serum levels are often caused by liver and liver and bone diseases. Also, the presence of elevated levels of the enzyme in serum after administration of drugs and experimental therapeutic agents is associated with organ toxicity. Therefore, monitoring serum levels of AP enzyme has become a routine method to monitor drug toxicity. MaxDiscovery™ Alkaline Phosphatase Enzymatic Assay Kit uses an enzymatic assay to determine the amount of alkaline phosphatase in rodent serum and other liquid samples. The kit enables biomedical researchers to determine alkaline phosphatase levels in liquid samples such as serum. The MaxDiscovery™ Alkaline Phosphatase Enzymatic Assay Kit contains sufficient materials to test 42 samples in duplicate. The assay utilizes a simple colorimetric (visible) enzymatic assay to specifically detect AP in fluids. The MaxDiscovery™ Alkaline Phosphatase Enzymatic Assay Kit provides accurate, proven results even in complex liquid mixtures. The kit is designed to be used with a microplate reader. The kit contains a thymolphthalein standard to construct a linear calibration curve and verify assay performance.
Keeping Tumor Growth at Bay Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.Cancer Cells Kill Off Healthy Neighbours Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.Future of Medicine Could be Found in a Tiny Crystal Ball A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.Bile Acid Supports Production of Blood Stem Cells A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.Chemical Used to Replace BPA is Potentially Toxic This study is the first to examine the effects of BPA and BPS on brain cells and genes that control the growth and function of organs involved in reproduction.A Better Model for Parkinson's Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.Improving Delivery of Poorly Soluble Drugs Using Nanoparticles A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.Toxicity Testing With Cultured Liver Cells Microreactor replaces animal testing. Neural Networks Adapt to the Presence of a Toxic HIV Protein HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.Faster Drug Discovery? Startup develops more cost-effective test for assessing how cells respond to chemicals.